SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-125169
Filing Date
2023-12-12
Accepted
2023-12-12 07:00:20
Documents
13
Period of Report
2023-12-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332667d1_8k.htm   iXBRL 8-K 27569
5 GRAPHIC tm2332667d1_8kimg001.jpg GRAPHIC 354400
  Complete submission text file 0001104659-23-125169.txt   1028632

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA btai-20231212.xsd EX-101.SCH 3048
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE btai-20231212_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btai-20231212_pre.xml EX-101.PRE 22381
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2332667d1_8k_htm.xml XML 3312
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 231479928
SIC: 2834 Pharmaceutical Preparations